Neurodegenerative Diseases Program
Alzheimer's Disease, Parkinson's Disease, ALS, Lewy Body Dementia
Pre-clinicalActive
Key Facts
Indication
Alzheimer's Disease, Parkinson's Disease, ALS, Lewy Body Dementia
Phase
Pre-clinical
Status
Active
Company
About SeNostic
SeNostic is a private, pre-revenue diagnostics and drug discovery platform company targeting neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS, as well as Type 2 Diabetes. Its proprietary SeedCycler® technology utilizes a protein amplification method, similar to PCR, to detect and analyze disease-specific misfolded protein aggregates (e.g., α-synuclein, amyloid-β) from biofluids. The company aims to serve the high-unmet-need markets of early disease diagnostics, patient stratification for clinical trials, and pre-clinical drug screening, with a business model encompassing device sales, consumables, assays, and recombinant protein reagents.
View full company profile